心血管疾患におけるS-ニトロシル化: 最新技術
Caiyun Mao1, Jieyou Zhao2, Nana Cheng2
1Department of Pharmacology, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Biomolecules
|August 28, 2025
まとめ
タンパク質の機能に影響を与える重要な変化であるS-ニトロシレーションは,心臓血管の健康と疾患において極めて重要です. S-ニトロシル化タンパク質の理解は,心臓血管疾患の新たな治療目標を提供します.
科学分野:
- 生物化学
- 心血管生物学
- 分子医学
背景:
- タンパク質S-ニトロシレーションは,ニトロシル基をシステインに結合させ,S-ニトロシオールを形成する.
- 心血管の生理学と病理学を調節するために,この翻訳後の修正は不可欠です.
- 調節不良のS-ニトロシレーションは,多くの心血管疾患に関連しています.
研究 の 目的:
- 心血管疾患に関与するS-ニトロシル化タンパク質を 検討する.
- これらのタンパク質がシグナル伝達経路を通じて病気の発生に与える影響を明らかにする.
- 標的型治療戦略を開発するための基礎を提供すること.
主な方法:
- 心血管疾患におけるS- ニトロシル化に関する研究の文献レビュー.
- S-ニトロシル化タンパク質によって影響される信号経路の分析.
- 病気の進行におけるS-ニトロシレーションの役割に関する情報の合成
主要な成果:
- S-ニトロシレーションはタンパク質の形状,活性,安定性を調節し,心臓および血管機能に影響を与えます.
- 異常なS- ニトロシル化濃度は高血圧,動脈硬化症,心不全,糖尿病性心筋病と関連しています.
- S-ニトロシレーションが不足すると血管拡張が低下し,過剰な量では心臓の縮や線維症が起こります.
結論:
- S-ニトロシレーションは,心血管の恒常性および疾患の重要な調節因子です.
- S-ニトロシル化タンパク質をターゲットにすることで 心血管新生疾患の新たな治療法に 期待が寄せられます
- S- ニトロシル化タンパク質に関するさらなる研究は,心血管疾患の治療戦略を前進させることができます.
関連する概念動画
Antianginal Drugs: Nitrates and β-Blockers
749
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
749
Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
213
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
Nitric Oxide Signaling Pathway
5.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
45
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
45


